Potassium Situations Resolved

Slides:

Advertisements

Similar presentations

Effect of Health Contract Intervention on Renal Disease Patients in Korea Penny Hall RN BSN December 12, 2013 Penny Hall RN BSN December 12, 2013.

Advertisements

Elimination of Phosphate in HD and PD Reference: Kuhlmann MK. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purif.

1 Future Areas of Research Intervention Approaches Causes and Mechanisms of Overweight and Obesity Abdominal Fat, Body Weight and Disease Risk Assessment.

Chronic Kidney Disease-Mineral and Bone Disorder

Diseases of the Renal System KNH 413. CKD - Renal Replacement Therapy Hemodialysis (HD) or Peritoneal Dialysis (PD) Type based on underlying kidney disease.

UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:

The Patient Experience With Systemic Lupus Erythematosus

Prior Trials of RAAS Inhibitors

Diseases of the Renal System

CHA2DS2-VASc Scoring System General AF Treatment Guidance.

Key Issues in Depression: Highlights From APA 2016

Emerging Concepts in Heart Failure

Current State of Hyperkalemia Management

NOACs for Cancer-Associated Thrombosis:

Introduction: Alarming Statistics Causes of Death in Prevalent Dialysis Patients,

Starting Strong: Initial Evaluation of the Patient With HCV

PCP Perspectives Pathophysiologic Principles in the Management of Hyperkalemia.

Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.

New Therapies for Hyperkalemia Across the Continuum of Care

Best Practices in Huntington Disease

A CASE CHALLENGE IN HFrEF:

Does One Size Fit All in Obesity Management?

At The Cutting Edge of Developments in the Management of Hyperkalemia

Updates Abound in Hyperkalemia Management

PCP Perspectives Clinical Considerations in Hyperkalemia

SGLT2 Inhibitors in the Modern Era: Why and Where?

Iron Deficiency Anemia

Bushinsky et al. Am J Nephrol 2016;44: (DOI: / )

When Would You Use Single Inhaler Triple Therapy in COPD?

HIV-Associated Weight Loss and Wasting

Talking to Patients About Diabetes Management

Expert Perspectives on Hyperkalemia for the Specialist

Addressing Challenges in Factor VIII Inhibitors in Children With Hemophilia.

Team-Based Perspectives on Successful Approaches in Treating Obesity

Postpartum Depression

Advances in the Management of Severe and Life-Threatening Chemotoxicity.

Improving Outcomes in OSA

Exploring Emerging Treatments for Hyperkalemia

At The Cutting Edge of Developments in the Management of Hyperkalemia

PCSK9 Inhibitors – A Leap in the Evolution of Dyslipidemia Management?

Multidisciplinary Management of Hyperkalemia:

Hyperkalemia in the Hospital

Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.

Managing CKD-Associated Anemia in Challenging Patients

Systemic Lupus Erythematosus

Management of Systemic Lupus Erythematosus

Nutrient Non-equivalence: Does Restricting High-Potassium Plant Foods Help to Prevent Hyperkalemia in Hemodialysis Patients? David E. St-Jules, RD, PhD,

Are We Making Progress in the Management of Huntington Disease?

The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.

A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.

Communicating With Your Patients About Major Depressive Disorder

Maximizing Organ Protection in Patients With CKD and Comorbidities on RAAS Therapy.

Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought Nicolas Rognant, Maurice Laville Kidney.

Improving Adherence to Antiplatelet Therapy After an ACS Event

Perspective on the Multidisciplinary Management of PAH

Assessing the Burden of Hyperkalemia

Saving the Day.

Breaking Down the Data in Hyperkalemia

HF-Related Hospitalization and Readmissions

Dialysate Sodium: Choosing the Optimal Hemodialysis Bath

Assessing the Burden of Hyperkalemia

Championing Evidence-Based Care in Patients With Acute Low Back Pain

Diseases of the Renal System

Clinical Comparisons.

My PAH Patient.

RAASi Enabling in the Modern Era

Risk Stratification in MDS

Case-Based Look at Hyperkalemia Identification, Diagnosis, and Management.

The causes and treatment of hyperkalemia across the continuum of kidney function and with kidney replacement therapies. The causes and treatment of hyperkalemia.

Presentation transcript:

Potassium Situations Resolved

Relationship Between Potassium Level and Risk of Mortality

Dietary Restriction of Potassium Intake

Current Pharmacologic Interventions of the RAAS

Impact of RAAS Inhibition on K+ Levels in HD Patients

Caution Regarding RAAS Inhibitors Predialysis

Patient Case

Rule of 7s

Hyperkalemia Assessment in a Patient on HD

Patient Case: Zero K+ Bath

Response of Plasma Potassium to K+ Removal by Dialysis

SPS for the Treatment of Hyperkalemia

Patiromer and SZC*

Managing K+ in Patients on HD: Moving Forward

DIALIZE Study

Potential Future Studies to Assess Utility of K+ Binders in Patients on HD

DIALIZE: Interdialytic Weight Gain

Patiromer HD Study

Patiromer HD Study: Results

Team-Based Care Among Different Specialties for Improved Care of Patients on Dialysis

Abbreviations

Abbreviations (cont)